Passwords: BioTech and Pharma Both Need a New Path
A year ago, Chris Pierson and BlackCloak studied executives at top global pharma companies to learn the extent of password-based vulnerabilities. The findings weren't reassuring. Pierson revisited the study this year with a select few entities to see if the needle has moved in a more secure direction.
In a video interview with Information Security Media Group, Pierson discusses:
- Results of his latest research;
- Lessons that remain to be learned about password-based vulnerabilities;
- Tips to help protect senior leaders in their lives outside the office.
Pierson is the founder and CEO of BlackCloak – a concierge cybersecurity protection suite for high-net-worth individuals and top C-Suite executives. BlackCloak protects its customers from financial loss, cybercrime, hacking, reputational damage, privacy exposure and identity theft. In addition to his role at BlackCloak, Pierson serves on the Department of Homeland Security’s Data Privacy and Integrity Advisory Committee and the DHS Cybersecurity Subcommittee. He has been on the front lines of cybersecurity and fighting cybercrime for over 20 years – with DHS, as president of the Federal Bureau of Investigation’s Arizona Infragard and as a chief information security officer for financial companies. He was a founding executive of Viewpost, a FinTech payments company, and served as its CISO and general counsel. He was the first chief privacy officer, SVP for the Royal Bank of Scotland’s U.S. operations and was a corporate attorney at Lewis Roca Rothgerber Christie, for which he established a cybersecurity practice.